[Therapy of acute mayocardial infarction: COMMIT (Clopidogrel and Metoprolol Infarction Trial)].
Bode
C
C
Abteilung für Kardiologie und Angiologie, Medizinische Klinik der Universitätsklinik, Hugstetter Strasse 55, 79106, Freiburg. christoph.bode@uniklinik-freiburg.de
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D000077144:Clopidogrel; D004338:Drug Combinations; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016019:Survival Analysis; D015996:Survival Rate; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D008790:Metoprolol; D013988:Ticlopidine